Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA007041 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA007041, RRID:AB_1078097
- Product name
- Anti-ACVRL1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ACVRL1, Gene description: activin A receptor type II-like 1, Alternative Gene Names: ACVRLK1, ALK1, HHT, HHT2, ORW2, Validated applications: WB, IHC, Uniprot ID: P37023, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Decreased Colonic Activin Receptor-Like Kinase 1 Disrupts Epithelial Barrier Integrity in Patients With Crohn’s Disease
The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal Arterioles Declines During Progression of Alzheimer's Disease.
Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
Toyonaga T, Steinbach E, Keith B, Barrow J, Schaner M, Wolber E, Beasley C, Huling J, Wang Y, Allbritton N, Chaumont N, Sadiq T, Koruda M, Jain A, Long M, Barnes E, Herfarth H, Isaacs K, Hansen J, Shanahan M, Rahbar R, Furey T, Sethupathy P, Sheikh S
Cellular and Molecular Gastroenterology and Hepatology 2020;10(4):779-796
Cellular and Molecular Gastroenterology and Hepatology 2020;10(4):779-796
The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal Arterioles Declines During Progression of Alzheimer's Disease.
Anderson KE, Bellio TA, Aniskovich E, Adams SL, Blusztajn JK, Delalle I
Cerebral cortex communications 2020;1(1):tgaa031
Cerebral cortex communications 2020;1(1):tgaa031
Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
Adams SL, Benayoun L, Tilton K, Mellott TJ, Seshadri S, Blusztajn JK, Delalle I
Journal of Alzheimer's disease : JAD 2018;63(4):1433-1443
Journal of Alzheimer's disease : JAD 2018;63(4):1433-1443
Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
Cunha SI, Pardali E, Thorikay M, Anderberg C, Hawinkels L, Goumans MJ, Seehra J, Heldin CH, ten Dijke P, Pietras K
The Journal of experimental medicine 2010 Jan 18;207(1):85-100
The Journal of experimental medicine 2010 Jan 18;207(1):85-100
No comments: Submit comment
No validations: Submit validation data